Document Detail

Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory.
MedLine Citation:
PMID:  23374099     Owner:  NLM     Status:  Publisher    
The assessment of recombinant FVIII (rFVIII) activity (FVIII:C) in plasma of patients is dependent on the assay. Notably, a calibration with a product-specific laboratory standard is recommended when measuring Refacto-AF(R) activity in plasma with a one-stage assay. The objective of this study was to facilitate the measurement of rFVIII, taking into account the recent demonstration that a calibration curve does not have to be included in each run. FVIII:C was measured in patients' samples after infusion of different types of rFVIII with a one-stage and a chromogenic assay calibrated either with pooled normal plasma or a product-specific laboratory standard. Results obtained with the one-stage coagulation assay were compared with these provided by a chromogenic assay. We confirmed that a calibration curve can be used for a prolonged period of time without loss of precision and accuracy. In such conditions, a stable relation between the calibration curves generated with a product-specific laboratory standard and plasma can be established. In patients' plasma, Refacto-AF levels measured with a one-stage FVIII assay calibrated with plasma or a product-specific laboratory standard diverged from -58% to -17% and from -25% to +18%, respectively, from the activity determined with a chromogenic substrate assay. By comparison, FVIII:C levels of full-length rFVIII measured with the one-stage assay calibrated with plasma were 6-49% lower than with the chromogenic assay. In a monocentric setting, the long-term stability of the calibration curves allows the implementation of a practical and cost-effective approach to determine rFVIII:C levels.
M Cauchie; J Toelen; K Peerlinck; M Jacquemin
Related Documents :
23376599 - Concentrations of organochlorine pesticides (ocps) in human blood plasma from hong kong...
23351309 - Co-administration of methyl donors along with guanidinoacetic acid reduces the incidenc...
23279319 - Serum rantes level influences the response to pegylated interferon and ribavirin therap...
23572709 - Effect of incorporation of chicken blood plasma on physico-chemical properties of cakes.
24263449 - Erythrocyte and plasma trace element levels in clinical assessments : zinc, copper, and...
24593569 - Arc plasma generator of atomic driver for steady-state negative ion source.
7362859 - Prematurity in the rat. ii. effect of hypothermia.
2138079 - Treatment of children with central precocious puberty by a slow-release gonadotropin-re...
22891879 - Plasma microrna-21 concentration may be a useful biomarker in glioblastoma patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-4
Journal Detail:
Title:  Haemophilia : the official journal of the World Federation of Hemophilia     Volume:  -     ISSN:  1365-2516     ISO Abbreviation:  Haemophilia     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9442916     Medline TA:  Haemophilia     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present).
Next Document:  Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease.